Partnership between WraSer and Pedinol Pharmacal, Inc.
May 1, 2011
For Immediate Release
WraSer Pharmaceuticals, LLC announces an exclusive co-detail of Nalfon® capsules (fenoprofen calcium, USP) 200mg and 400mg from Pedinol Pharmacal, Inc.
Ridgeland, MS (May 1, 2011) – WraSer Pharmaceuticals, LLC (WraSer) announced today it has entered into an exclusive co-detail agreement with Pedinol Pharmacal, Inc. (PedinolTM) to market Nalfon capsules in all specialties outside of podiatry.
Nalfon® 400 received final FDA approval in July 2009. The product offers the Non-Steroidal Anti-Inflammatory Drug “NSAID” (fenoprofen calcium), representing therapy for the relief of mild to moderate pain, signs and symptoms of rheumatoid arthritis and signs and symptoms of osteoarthritis*. Physicians have few promoted and sampled prescriptions NSAIDs. Nalfon® is one of the few remaining NSAIDs to provide physicians support and samples for effective pain relief.
“WraSer is pleased to add this effective therapy to our portfolio of pain management products” said Ford Mundy, Brand Manager for WraSer. “WraSer is excited to provide an NSAID treatment option to the physicians and patients we serve. Nalfon® is a great complement to our current and growing set of offerings in this market.”
“We are happy to enter this agreement with WraSer, which will result in more physicians and their patients experiencing the benefits of Nalfon®” said Scott Florentino, Manager of Commercial Development for Pedinol.
Nalfon® is available immediately to retail pharmacies and wholesale pharmacy distribution channels and is available by prescription only. For full prescribing information, please contact WraSer at the contact number listed below or visit www.nalfon.com*.
About WraSer Pharmaceuticals, LLC
WraSer is a privately held specialty pharmaceutical company headquartered in Ridgeland, MS. The company actively markets prescription pharmaceutical products focused on primary care, pediatric and dermatological markets. WraSer markets its products through its proprietary sales force. The company is continually expanding its product portfolio through direct development, FDA submissions, partnerships and in-licensing agreements. Further information regarding WraSer is available at www.wraser.com.
About PEDiNOL Pharmacal, Inc.
PEDiNOL Pharmacal, Inc. is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.
WraSer Pharmaceuticals, LLC
Posted on 5/16/2011
View All Postings